Results 41 to 50 of about 943 (143)

Progression of Subclinical Pachychoroid Neovasculopathy to an Active Neovascularization in the Presence of Acquired Vitelliform Lesions. [PDF]

Case Rep Ophthalmol Med, 2021
We describe a unique case of bilateral acquired vitelliform lesions in a 67‐year‐old‐female with pachychoroid associated with subretinal fluid in the right eye (OD) and a nonexudative choroidal neovascular membrane (CNVM) in the left eye (OS). Multimodal imaging performed at baseline and over the ensuing two years showed an increase in the OS ...
Soman M, Iqbal S, Sheth JU, Meleth P, Nair U.   +4 more
europepmc   +2 more sources

An improvement in visual acuity accompanied by the development of RPE tear: a case report

BMC Ophthalmology
Background Retinal pigment epithelium (RPE) tear is a well-known complication of RPE detachment and is typically associated with significant visual acuity decline.
Xinyu Liu, Shulin Liu, Zhiyan Xu, Youxin Chen   +3 more
doaj   +2 more sources

Characteristics of pachychoroid neovasculopathy. [PDF]

Sci Rep, 2020
AbstractRecently, several research groups have reported a newly recognized clinical entity of choroidal neovascularization, termed pachychoroid neovasculopathy. However, its characteristics have yet to be well described. The purpose of this study was to investigate the clinical and genetic characteristics of pachychoroid neovasculopathy regardless of ...
Tagawa M, Ooto S, Yamashiro K, Tamura H, Oishi A, Miyata M, Hata M, Yoshikawa M, Yoshimura N, Tsujikawa A.   +9 more
europepmc   +4 more sources

Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-Svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy [PDF]

Journal of Clinical Medicine
Seongyong Jeong, Min Sagong
exaly   +2 more sources

Characteristics and Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in a Large Cohort of Patients With Pachychoroid Neovasculopathy [PDF]

Journal of Vitreoretinal Diseases
Amit Mishra, Parampal S Grewal, Graeme K Loh   +2 more
exaly   +2 more sources

Active concurrent central serous chorioretinopathy and pachychoroid neovasculopathy managed with combination therapy of photodynamic therapy and anti-vascular endothelial growth factor agent

Indian Journal of Ophthalmology. Case Reports, 2021
Pachychoroid disease spectrum includes central serous chorioretinopathy (CSR) and pachychoroid neovasculopathy (PNV). Pachychoroid phenotype is characterized by choroidal hyperpermeability, dilated choroidal vessels (pachyvessels), and focal or diffuse ...
Barun Garg, Isha Gupta, Sugandha Goel, Deepak Senger, Kumar Saurabh, Rupak Roy   +5 more
doaj   +1 more source

Central serous chorioretinopathy: A review

Clinical &Experimental Ophthalmology, Volume 51, Issue 3, Page 243-270, April 2023., 2023
Abstract Central serous chorioretinopathy (CSC) is the fourth most common non‐surgical retinopathy associated with fluid leakage. The pathogenesis is not yet completely understood, but changes in the choroid, sclera and RPE have been described associated with venous congestion of choroidal outflow.
Adrian T. Fung, Yi Yang, Andrew W. Kam
wiley   +1 more source

Choroidal arteriovenous anastomoses: a hypothesis for the pathogenesis of central serous chorioretinopathy and other pachychoroid disease spectrum abnormalities

Acta Ophthalmologica, Volume 100, Issue 8, Page 946-959, December 2022., 2022
Abstract The pachychoroid disease spectrum (PDS) includes several chorioretinal diseases that share specific choroidal abnormalities. Although their pathophysiological basis is poorly understood, diseases that are part of the PDS have been hypothesized to be the result of venous congestion.
Joost Brinks, Elon H. C. van Dijk, Onno C. Meijer, Reinier O. Schlingemann, Camiel J. F. Boon   +4 more
wiley   +1 more source

Pachychoroid Spectrum Disorder Findings in Patients with Coronavirus Disease 2019

Case Reports in Ophthalmological Medicine, Volume 2021, Issue 1, 2021., 2021
Purpose. To report the occurrence of acute, bilateral, central serous chorioretinopathy (CSC), and pachychoroid spectrum disorder findings in patients with coronavirus disease 2019 (COVID‐19). Methods. In recovered cases of COVID‐19 with visual disturbances, complete ocular examinations with multimodal retinal and choroidal evaluation, including ...
Mojtaba Abrishami, Ramin Daneshvar, Nasser Shoeibi, Neda Saeedian, Hamid Reza Heidarzadeh, Seyedeh Maryam Hosseini, Stephen G. Schwartz   +6 more
wiley   +1 more source

Anatomical and Functional Outcomes of Anti-VEGF Therapy in Pachychoroid Neovasculopathy. [PDF]

Clin Ophthalmol
Evaluation of real-life effectiveness of anti-VEGF therapy in patients diagnosed with pachychoroid neovasculopathy (PNV).This retrospective analysis included central serous chorioretinopathy (CSC) patients who developed PNV and underwent anti-VEGF treatment. Individuals with concomitant retinal diseases were excluded.
Sitnilska V, Pohl JM, Tang Y, Löw K, Lammert JQ, Krohne TU, Altay L.   +6 more
europepmc   +5 more sources